Commercialization: Page 106
-
PharmaVoice Team/PharmaVoice
It All Comes Down to Creative
It All Comes Down to Creative The Hal Lewis Group Inc. VIEW on Advertising March 2006 Creative work must be the sound, smart, clever, intuitive, provocative, compelling expression of the brand strategy. Separate them at your peril. Peter Siegel, Executive Creative Direct...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
April 2006 On the Calendar April 17-19 2006 World Health Care Congress Marriott Wardman Park Hotel, Washington, D.C. PharmaVOICE is exhibiting at this event. For more information, contact Tracey Fielding, World Congress, at 781-939-2555, e-mail [email protected], or visit worldcongress...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Drugs in the Real World
By Denise Myshko A greater regulatory focus on safety means companies are under pressure to provide more information about a prescription drug, as well as about the characteristics of patients, once a product becomes available to the larger marketplace. companies are being asked to provide inform...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Steve Andrzejewski Eric J. Bruce Rick Kelly Dan McCall Robert Murphy Adriana Sax King Pharmaceuticals Hires and Promotes King, Bristol, Tenn., a vertically integrated branded pharmaceutical company, has appointed Steve Andrzejewski to chief commercial officer. His new responsibilities...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Times are Changing
Times are Changing By Daniel Limbach What a difference a year makes. While 2005 will be remembered by pharmaceutical companies as a year of great change, 2006 will be thought of as the year of changing strategies. any pharmaceutical companies that depend...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Shifting the Pediatrics Paradigm
By Autumn Konopka The FDA’s push for pediatric studies since the late 1990s has nearly doubled the pediatrics market, which is expected to keep growing in the coming years. Nevertheless, children remain “therapeutic orphans,” and some experts believe that the pediatrics market may never be able t...
By Autumn Konopka • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
Elsevier MDL Introduces Electronic Lab Notebook Elsevier MDL has launched MDL Notebook, the initial release of its major electronic lab notebook (ELN) initiative. MDL Notebook brings systematic efficiency to fundamental research activity by streamlining workflows, improving productivity, and inte...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Anybody who has a parent or parents who are in the senior bracket are familiar with the complexities of Medicare Part D. Even those of us in the industry are stumped by the different nuances of this new plan. With enrollment in full swing, Medicare Part D is having a significant impact on the ind...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single branding elements. Cr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New Prescription Drug Information Format to Improve Patient Safety The FDA is seeking to reduce the complexity of information on prescription drug labels, making them more useful for physicians and patients. The U.S. Food and Drug Administration (FDA) has unveiled a major revision to the format o...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Prescription for Success in Globalization
Prescription for Success in Globalization VIEW on a common global language Sig Shirodkar, Principal, and Mark Mozeson, Principal and life sciences Practice Leader, both of Archstone Consulting, discuss why designing a set of corporate attributes and standards of behavior is the key to global succ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Value of Journal Advertising
By Autumn Konopka Advertising in medical journals, while underused in the past according to most experts, does provide value to pharmaceutical marketers. Experts say recent industry trends are likely to encourage pharma companies to focus more of their efforts on journal advertising in the future...
By Autumn Konopka • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
March 2006 Table of Contents Warren Levy says Medicare Part D is a catalyst for change. Journal ads should be tied in with other tactics that companies are employing, says Robert Osborn. Prof. Herrling believes drug discovery requires input from multiple disciplines. On the Cover Managing marketi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
Medicare Part D Marketing Opportunities and Challenges In the Lab with Prof. Paul Herrling Journal Advertising The Pediatric Drug Market March 2006 www.pharmavoice.com Volume 6, Issue 3 The forum for the industry executive Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Regulatory Deficiency is High Among Non-U.S. Clinical Investigators In a sharp reversal of previous trends, good clinical practice (GCP) deficiency rates for non-U.S.-based clinical investigators have surged past the corresponding rates for U.S.-based investigators. This is the finding of The Glo...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
the winner is … HBA 2006 Woman of the Year Susan Desmond-Hellmann, M.D., President of Product Development at Genentech, has been named the 2006 Woman of the Year by the Healthcare Businesswomen’s Association (HBA). Dr. Desmond-Hellmann is credited with possessing extraordinary leadership, unwaver...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
The Perfect Job Is There For The Asking Contributed by Shellie Caplan This is such an exciting time in the industry, especially for people in marketing. With some personal insight, and recognition of the opportunities that exist within the healthcare field, the perfect job can be obtained. Tradit...
By Shellie Caplan • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Consumer Health Market Trends Show Continued Interest in E-Based Sources The population of consumers using the Internet as their primary learning channel for health information continued an upward trajectory in 2005, with 31.6 million consumers reporting that the Internet is their first stop when...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Pharmaceutical Consumerism and the Next Phase of Drug Promotion Contributed by Russell LaMontagne For the last decade, many have argued that direct-to-consumer (DTC) advertising is bad for consumers. At the end of the 1990s, when drug costs exceeded hospital costs for the first time, critics of t...
By Russell LaMontagne • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Stopping power seems to be harder to achieve these days with DTC print ads. Predictablity has become the woeful result of having to present legal mandatories, client “requests” for a bigger logo, oh — and not to forget — some kind of sell crammed in whatever space is left. The result is often a 5...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Drug Delivery: A Pipeline of Research and Market Opportunities
By Denise Myshko Delivery technologies will play an increasingly important role in the drug-development process as a means to improve the efficacy of a drug; make a drug safer, more effective, or convenient; extend its patent life; or differentiate it in the marketplace. In recent years, there ha...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Marketing is everything that a company does to reach and persuade prospects. The sales process is everything that a company does to close the sale and get a signed agreement or contract. Despite having objectives that would appear to be in sync, it’s not uncommon for a company to be unbalanced wh...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Creating A New Culture -- Hiromi Yoshikawa
After significant accomplishments that helped put Otsuka on the map — a major systems implementation in China and the establishment of Otsuka business entities in Europe — Hiromi Yoshikawa is establishing new business dynamics at Otsuka America Pharmaceutical Inc. Loyalty is central to Hiromi Y...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Marketing to Real Life Frasiers & Mirandas
Marketing to Boomers Marketing to Real Life Frasiers & Mirandas Lori Laurent Smith and David Lockwood, both of Campbell-Ewald Health, discuss why the time is ripe for the healthcare community to support the growing population of boomer caregivers. Pharma marketers need to connect with each bo...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
The Forum for the Industry Executive Cover February 2006 Bridging the Gap Between Sales & Marketing Creating a New Culture with Hiromi Yoshikawa Advancements in Drug Delivery The Depression Market Download PDF
By PharmaVoice Team • Jan. 2, 2008
Previous
